AAAAAA

   
Results: 1-7 |
Results: 7
THE NONPEPTIDE NK-1 RECEPTOR ANTAGONIST LY303870 INHIBITS NEUROGENIC DURAL INFLAMMATION IN GUINEA-PIGS
Authors: PHEBUS LA JOHNSON KW STENGEL PW LOBB KL NIXON JA HIPSKIND PA
Citation: La. Phebus et al., THE NONPEPTIDE NK-1 RECEPTOR ANTAGONIST LY303870 INHIBITS NEUROGENIC DURAL INFLAMMATION IN GUINEA-PIGS, Life sciences, 60(18), 1997, pp. 1553-1561
LY303870, A CENTRALLY ACTIVE NEUROKININ-1 ANTAGONIST WITH A LONG-DURATION OF ACTION
Authors: IYENGAR S HIPSKIND PA GEHLERT DR SCHOBER D LOBB KL NIXON JA HELTON DR KALLMAN MJ BOUCHER S COUTURE R LI DL SIMMONS RMA
Citation: S. Iyengar et al., LY303870, A CENTRALLY ACTIVE NEUROKININ-1 ANTAGONIST WITH A LONG-DURATION OF ACTION, The Journal of pharmacology and experimental therapeutics, 280(2), 1997, pp. 774-785
POTENT AND SELECTIVE 1,2,3-TRISUBSTITUTED INDOLE NPY Y-1 ANTAGONISTS
Authors: HIPSKIND PA LOBB KL NIXON JA BRITTON TC BRUNS RF CATLOW J DIECKMANMCGINTY DK GACKENHEIMER SL GITTER BD IYENGAR S SCHOBER DA SIMMONS RMA SWANSON S ZARRINMAYEH H ZIMMERMAN DM GEHLERT DR
Citation: Pa. Hipskind et al., POTENT AND SELECTIVE 1,2,3-TRISUBSTITUTED INDOLE NPY Y-1 ANTAGONISTS, Journal of medicinal chemistry, 40(23), 1997, pp. 3712-3714
3-ARYL-1,2-DIACETAMIDOPROPANE DERIVATIVES AS NOVEL AND POTENT NK-1 RECEPTOR ANTAGONISTS
Authors: HIPSKIND PA HOWBERT JJ BRUNS RF CHO SSY CROWELL TA FOREMAN MM GEHLERT DR IYENGAR S JOHNSON KW KRUSHINSKI JH LI DL LOBB KL MASON NR MUEHL BS NIXON JA PHEBUS LA REGOLI D SIMMONS RM THRELKELD PG WATERS DC GITTER BD
Citation: Pa. Hipskind et al., 3-ARYL-1,2-DIACETAMIDOPROPANE DERIVATIVES AS NOVEL AND POTENT NK-1 RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 39(3), 1996, pp. 736-748
PHARMACOLOGICAL CHARACTERIZATION OF LY303870 - A NOVEL, POTENT AND SELECTIVE NONPEPTIDE SUBSTANCE-P (NEUROKININ-1) RECEPTOR ANTAGONIST
Authors: GITTER BD BRUNS RF HOWBERT JJ WATERS DC THRELKELD PG COX LM NIXON JA LOBB KL MASON NR STENGEL PW COCKERHAM SL SILBAUGH SA GEHLERT DR SCHOBER DA IYENGAR S CALLIGARO DO REGOLI D HIPSKIND PA
Citation: Bd. Gitter et al., PHARMACOLOGICAL CHARACTERIZATION OF LY303870 - A NOVEL, POTENT AND SELECTIVE NONPEPTIDE SUBSTANCE-P (NEUROKININ-1) RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 737-744
PRACTICAL AND ENANTIOSPECIFIC SYNTHESIS OF LY303870, A NOVEL NK-1 ANTAGONIST
Authors: HIPSKIND PA HOWBERT JJ CHO S CRONIN JS FORT SL GINSH FO HANSEN GJ HUFF BE LOBB KL MARTINELLI MJ MURRAY AR NIXON JA STASZAK MA COPP JD
Citation: Pa. Hipskind et al., PRACTICAL AND ENANTIOSPECIFIC SYNTHESIS OF LY303870, A NOVEL NK-1 ANTAGONIST, Journal of organic chemistry, 60(21), 1995, pp. 7033-7036
DIPHENYLPYRAZOLIDINONE AND BENZODIAZEPINE CHOLECYSTOKININ ANTAGONISTS- A CASE OF CONVERGENT EVOLUTION IN MEDICINAL CHEMISTRY
Authors: HOWBERT JJ LOBB KL BRITTON TC MASON NR BRUNS RF
Citation: Jj. Howbert et al., DIPHENYLPYRAZOLIDINONE AND BENZODIAZEPINE CHOLECYSTOKININ ANTAGONISTS- A CASE OF CONVERGENT EVOLUTION IN MEDICINAL CHEMISTRY, Bioorganic & medicinal chemistry letters, 3(5), 1993, pp. 875-880
Risultati: 1-7 |